By: John Tozzi, Ike Swetlitz, Tanaz Meghjani
New data show how often insurers deny prior authorizations that can stall patients’ care — and how frequently those decisions get reversed.
Ike Swetlitz is a Health Reporter at various prominent publications. He focuses on themes related to healthcare administration, patient care, and public health, while also covering topics in finance and business economics as they intersect with health and wellness. Ike's work has been featured in notable outlets including Financial Post, Bloomberg Law, TIME, and Fortune.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Ike Swetlitz's coverage focuses heavily on healthcare and pharmaceuticals, particularly emphasizing drug shortages, FDA announcements, and data-driven reporting. To effectively reach out to Ike, consider providing insights or data-based analysis related to the pharmaceutical industry, healthcare policies, drug shortages, or FDA regulations.
Given the prevalence of government announcements in his coverage attributes, pitches that provide expert commentary on government health policies or insightful analyses into how these policies impact the pharmaceutical industry could be well received by Ike.
Considering his extensive focus on specific companies such as Teva and Bluebird as well as broader topics like ADHD medication and cancer drugs might make him interested in receiving pitches regarding developments within these specific companies or around advancements related to ADHD medication and cancer drugs.
This information evolves through artificial intelligence and human feedback. Improve this profile .